Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.

doi:10.1093/jnci/djs486

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.

Journal of the National Cancer Institute - 6 Feb 2013

Haiman Christopher A, Stram Daniel O, Vickers Andrew J, Wilkens Lynne R, Braun Katharina, Valtonen-André Camilla, Peltola Mari, Pettersson Kim, Waters Kevin M, Marchand Loic Le, Kolonel Laurence N, Henderson Brian E, Lilja Hans

Abstract excerpt

BACKGROUND: A common genetic variant (rs10993994) in the 5' region of the gene encoding β-microseminoprotein (MSP) is associated with circulating levels of MSP and prostate cancer risk. Whether MSP levels are predictive of prostate cancer risk has not been evaluated. METHODS: We investigated the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to California

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hawaii

Share to Hispanic or Latino

Share to Native Hawaiian or Pacific Islander

Share to Predictive Value of Tests

Share to Prostatic Neoplasms

Share to Risk Assessment

Share to Surveys and Questionnaires

Source

Open in PubMed Open full text

Identifiers

PMID: 23213189
DOI: 10.1093/jnci/djs486
PMCID: PMC3565627

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23213189-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.PMID 23213189Read ↗

A common prostate cancer risk variant 5' of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations.Semantic proximity Read ↗

Polymorphisms at the Microseminoprotein-beta locus associated with physiologic variation in beta-microseminoprotein and prostate-specific antigen levels.Semantic proximity Read ↗

The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.Semantic proximity Read ↗

Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.Semantic proximity Read ↗

A meta-analysis of influence of MSMB promoter rs10993994 polymorphisms on prostate cancer risk.Semantic proximity Read ↗

Validation of prostate cancer risk variants by CRISPR/Cas9 mediated genome editingSemantic proximity Read ↗

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.Semantic proximity Read ↗

MSMB gene rs10993994 polymorphism increases the risk of prostate cancer.Semantic proximity Read ↗

Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.Semantic proximity Read ↗

The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target.Semantic proximity Read ↗

Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer.Semantic proximity Read ↗

Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.